Metabolic coordination of physiological and pathological cardiac remodeling

AA Gibb, BG Hill - Circulation research, 2018 - Am Heart Assoc
Metabolic pathways integrate to support tissue homeostasis and to prompt changes in cell
phenotype. In particular, the heart consumes relatively large amounts of substrate not only to …

Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies

BC Bernardo, KL Weeks, L Pretorius… - Pharmacology & …, 2010 - Elsevier
Cardiac hypertrophy can be defined as an increase in heart mass. Pathological cardiac
hypertrophy (heart growth that occurs in settings of disease, eg hypertension) is a key risk …

Electrical and mechanical stimulation of cardiac cells and tissue constructs

WL Stoppel, DL Kaplan, LD Black III - Advanced drug delivery reviews, 2016 - Elsevier
The field of cardiac tissue engineering has made significant strides over the last few
decades, highlighted by the development of human cell derived constructs that have shown …

[HTML][HTML] A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy

D Hilfiker-Kleiner, K Kaminski, E Podewski, T Bonda… - Cell, 2007 - cell.com
Postpartum cardiomyopathy (PPCM) is a disease of unknown etiology and exposes women
to high risk of mortality after delivery. Here, we show that female mice with a cardiomyocyte …

Mechanisms contributing to cardiac remodelling

QQ Wu, Y Xiao, Y Yuan, ZG Ma, HH Liao, C Liu… - Clinical …, 2017 - portlandpress.com
Cardiac remodelling is classified as physiological (in response to growth, exercise and
pregnancy) or pathological (in response to inflammation, ischaemia, ischaemia/reperfusion …

Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute

AR Hemnes, DG Kiely, BA Cockrill… - Pulmonary …, 2015 - journals.sagepub.com
Pregnancy outcomes in patients with pulmonary hypertension remain poor despite
advanced therapies. Although consensus guidelines recommend against pregnancy in …

Pathophysiology and epidemiology of peripartum cardiomyopathy

D Hilfiker-Kleiner, K Sliwa - Nature reviews cardiology, 2014 - nature.com
Cardiovascular diseases are a major cause of complications in pregnancy worldwide, and
the number of patients who develop cardiac problems during pregnancy is increasing …

Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.

JR McMullen, GL Jennings - Clinical & Experimental …, 2007 - search.ebscohost.com
In general, cardiac hypertrophy (an increase in heart mass) is a poor prognostic sign.
Cardiac enlargement is a characteristic of most forms of heart failure. Cardiac hypertrophy …

The myocardial JAK/STAT pathway: from protection to failure

K Boengler, D Hilfiker-Kleiner, H Drexler… - Pharmacology & …, 2008 - Elsevier
Proteins of the interleukin-6 (IL-6) family bind to receptors in the plasma membrane.
Subsequent signal transduction involves activation of the janus kinase (JAK) and signal …

[HTML][HTML] Effects of high intensity interval training on pregnant rats, and the placenta, heart and liver of their fetuses

NT Songstad, KHF Kaspersen, AD Hafstad, P Basnet… - PloS one, 2015 - journals.plos.org
Objective To investigate the effects of high intensity interval training (HIIT) on the maternal
heart, fetuses and placentas of pregnant rats. Methods Female Sprague-Dawley rats were …